Resources
Start and Stay on Therapy
For Novartis Patient Support resources, including the Start Form and Prior Authorization Appeals Kit, visit the Novartis Patient Support page.
Resources for Your Practice
Onboarding Guide
Help your patients along their treatment journey—a guide to resources to help patients start and stay on treatment with FABHALTA.
FABHALTA Electronic Health Record Guides
An EHR considerations checklist for development, configuration, and modification of EHR components that may be relevant to treatment with FABHALTA.
Resources for Your Patients
FABHALTA data is published in a peer-reviewed journal.
Novartis Pharmaceuticals Corporation markets FABHALTA (iptacopan) for the treatment of adults with paroxysmal nocturnal hemoglobinuria. Certain aspects of this information, including opinions of the authors, may be inconsistent with the final FDA-approved label. For questions regarding the publication, please contact US medical information at 1-888-669-6682 for more information.
Interested in learning more about how FABHALTA may help your adult patients with PNH?